Overview
SERA market data
Price History
SERA price chart · 1M
- O
- 2.11
- H
- 2.11
- L
- 2.00
- C
- 2.02
- Vol
- 1,589.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $2.11
- Previous Close
- $2.15
- Day High
- $2.11
- Day Low
- $2.00
- 52 Week High
- $2.30
- 52 Week Low
- $1.59
- 7 Day Return
- -2.42%
- 30 Day Return
- +0.50%
- 90 Day Return
- -6.70%
- 1 Year Return
- +0.75%
- Daily Notional Volume
- $3.2K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.67 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.01 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -56,386.0% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.56 – $3.95 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $78.7M · P/B 1.51 · P/S 1,380.86.
Company News
8-K filing — SERA PROGNOSTICS, INC. (SERA)SEC EDGAR · Aug 19, 2026, 9:05 PM
Sera Prognostics Names Scott Gleason As CFO, Effective August 31, 2026Benzinga · Aug 19, 2026, 8:32 PM
Sera Prognostics Q2 EPS $(0.18) Misses $(0.15) Estimate, Sales $30.000K Miss $57.500K EstimateBenzinga · Aug 12, 2026, 8:07 PM
Sera Prognostics Announces Publication Of New Subgroup Analysis From PRIME Randomized Controlled Trial, Highlighting Screening Efficiency And Potential Cost Savings In Large Underserved PopulationBenzinga · Jul 9, 2026, 8:15 PM
Sera Prognostics To Participate In A Multi-institutional Research Program That Was Awarded Up To $10.4M By The Advanced Research Projects Agency For Health To Develop A Novel Point-of-care Diagnostic Test Designed To Improve The Safety Of Labor And DeliveryBenzinga · Jun 24, 2026, 8:20 PM
Craig-Hallum Initiates Coverage On Sera Prognostics with Buy Rating, Announces Price Target of $6Benzinga · Jun 4, 2026, 5:45 PM